1. ICH Guideline M3(R2) on Non-clinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorisation for Pharmaceuticals,2010
2. ICH Guideline Q8(R2), Pharmaceutical Development,2009
3. Challenges in the development of high protein concentration formulations;Shire;J Pharm Sci,2004
4. Solubility principles and practices for parenteral drug dosage form development;Sweetana;PDA J Pharm Sci Technol,1996
5. A review of pH and Osmolarity;Stranz;Int J Pharm Compd,2002